Roberta Baronio

2.7k citations
22 papers · 2.0k · 1 hit paper · h-index 14

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer-related Molecular Pathways

Papers in

    • RNA modifications and cancer 5
    • Protein Degradation and Inhibitors 2
    • RNA Research and Splicing 2
    • Histone Deacetylase Inhibitors Research 2
    • Genomics and Phylogenetic Studies 2
    • Cancer-related Molecular Pathways 3

Roberta Baronio

20 papers receiving 1.9k citations

Roberta Baronio's Hit Papers

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort 2010 · 923 citations
9230+5+10Years since publication250500750

Peers

Roberta Baronio
Comparison fields: 5 of 102
  • Cancer Research 463
  • Oncology 718
  • Hematology 114
  • Molecular Biology 637
  • Radiology, Nuclear Medicine and Imaging 192
Replace Michael J. Wick with:
Michael J. Wick United States
Curtis R. Pickering United States
Kimberly J. Bussey United States
Andrea Bild United States
David Verbel United States
Byron Ellis United States
Fei Yang China
S Kern United States
Elton Rexhepaj Ireland
Mohamed E. Abazeed United States
Roberta Baronio relative to Michael J. Wick United States Michael J. Wick's profile →
Citations per field
00.5×1.5×2.1×
Michael J. Wick · 1×
Citations per year

Countries citing papers authored by Roberta Baronio

Since Specialization
Citations

This map shows the geographic impact of Roberta Baronio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Baronio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Baronio more than expected).

Fields of papers citing papers by Roberta Baronio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Baronio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Baronio. The network helps show where Roberta Baronio may publish in the future.

Co-authors

The 25 scholars most cited alongside Roberta Baronio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberta Baronio Line = papers co-authored together Roberta Baronio links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Hit paper breakdown →
2010923
2 2013186
3 2011175
4 2015137
5 2015112
6 2013109
7 200298
8 200953
9 200748
10 201135
11 201016
12 202414
13 201013
14
Countering Gattaca: Efficient and Secure Testing of Fully-Sequenced Human Genomes
201113
15 20148
16 20128
17
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53 - eScholarship
20136
18 20152
19 20241
20 20241

About Roberta Baronio

Roberta Baronio is a scholar working on Molecular Biology, Oncology, Artificial Intelligence, Physiology and Hematology, having authored 22 papers that have together received 2.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related Molecular Pathways (3 papers), Asthma and respiratory diseases (3 papers), Protein Degradation and Inhibitors (2 papers), RNA Research and Splicing (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Genomics and Phylogenetic Studies (2 papers). The work is most often cited by research in Cancer Research (463 citations), Oncology (718 citations), Hematology (114 citations), Molecular Biology (637 citations) and Radiology, Nuclear Medicine and Imaging (192 citations). Roberta Baronio has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Aňa Lluch, Federico Vázquez, Eva Ciruelos, José Baselga, S. Tjulandin, Claire Barton, Alexey Manikhas, А. А. Божок, Milvia Zambetti and Miguel Ángel Climent. Their work appears in journals such as PLoS Computational Biology, PLoS ONE, Pulmonary Pharmacology & Therapeutics, The Journal of Immunology and Biomolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact